ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Lees Pharmaceutical Holdings Ltd (PK)

Lees Pharmaceutical Holdings Ltd (PK) (LPCUF)

0,1903
0,00
(0,00%)
Fermé 05 Juillet 10:00PM

Lees Pharmaceutical Holdings Ltd (PK) (LPCUF) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
0,1903
( - )
Prix Achat
0,0001
Prix Vente
289 600,20
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,1882 Plage de 52 semaines 0,1903
Cap du marché
Clôture Veille
0,1903
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
US$ 775 233
Actions en circulation
588 835 343
Rendement du Dividende (LTM)
0,05 (4,13%)
Ratio Cours sur Bénéfices
6,6
Bénéfice par action (BPA)
0,16
Chiffre d'affairess (LTM)
1,44B
Bénéfice net (LTM)
91,94M

À propos de Lees Pharmaceutical Holdings Ltd (PK)

Lee's Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally. It focuses on various disease areas, such as cardiovascular, woman’s health, pediatrics, rare di... Lee's Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally. It focuses on various disease areas, such as cardiovascular, woman’s health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. It operates in Proprietary and Generic Products; and Licensed-In Products segments. The Proprietary and Generic Products segment manufactures and sells Nadroparin Calcium injection and Livaracine to treat blood clots and deep vein thrombosis; Yallaferon for viral infection; Slounase for hemostasis; Socazolimab Injection for Recurrent or metastatic cervical cancer; Treprostinil injection for pulmonary arterial hypertension; fondaparinux sodium injection for deep vein thrombosis; and Sodium Phenylbutyrate Granules to treat urea cycle disorders; Apremilast Tablets for Plaque psoriasis; and Azilsartan Tablets for hypertension. The Licensed-In Products segment offers Sancuso for chemotherapy induced nausea and vomiting; Bredinin to treat Immunosuppression in renal transplantation; Centraxal Plus for acute otitis media with tympanostomy tubes; and Ferplex to treat iron deficiency anemia. This segment also offers Intrarosa for vulvovaginal atrophy; Adasuve for agitation associated with schizophrenia or bipolar I disorder in adults; Mictonorm for urinary incontinence; Natulan for Stage III and IV Hodgkin’s disease; Lutrate for Prostate cancer; Nitric Oxide for Inhalation for Hypoxic respiratory failure associated with pulmonary hypertension; Omacor to treat Omega-3-acid ethyl esters; Zanidip for hypertension; Readyfusor for post-operative pain management; Teglutik to treat Amyotrophic lateral sclerosis; Trittico for insomnia/depression; Dicoflor and VSL#3 for probiotics; and Zingo for topical local analgesics. The company was founded in 1994 and is headquartered in Sha Tin, Hong Kong. Show more

Secteur
Healthcare
Industrie
Pharmaceuticals
Siège social
Sha Tin, Hong Kong
Fondé
1994
Lees Pharmaceutical Holdings Ltd (PK) est coté dans le secteur Healthcare de la OTC Markets avec le ticker LPCUF. Le dernier cours de clôture d'Lees Pharmaceutical (PK) était de US$0,19. Au cours de la dernière année, les actions de Lees Pharmaceutical (PK) ont été négociées dans une fourchette de prix de US$ 0,1882 à US$ 0,1903.

Lees Pharmaceutical (PK) compte actuellement 588 835 343 actions en circulation. La capitalisation boursière d'Lees Pharmaceutical (PK) est de US$112,06 million. Lees Pharmaceutical (PK) a un ratio cours/bénéfice (ratio PE) de 6.60.

LPCUF Dernières nouvelles

Aucune actualité à afficher pour le moment.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
12000.19030.19030.190300CS
26000.19030.19030.190300CS
520.00211.115834218920.18820.19030.1882190.1903CS
156-0.0097-4.850.20.20.1882260.18928182CS
260-1.3541-87.67806267811.54441.54440.00015530.28971906CS

LPCUF - Frequently Asked Questions (FAQ)

What is the current Lees Pharmaceutical Holdings Ltd (PK) share price?
The current share price of Lees Pharmaceutical Holdings Ltd (PK) is US$ 0,1903
How many Lees Pharmaceutical Holdings Ltd (PK) shares are in issue?
Lees Pharmaceutical Holdings Ltd (PK) has 588 835 343 shares in issue
What is the market cap of Lees Pharmaceutical Holdings Ltd (PK)?
The market capitalisation of Lees Pharmaceutical Holdings Ltd (PK) is USD 112,06M
What is the 1 year trading range for Lees Pharmaceutical Holdings Ltd (PK) share price?
Lees Pharmaceutical Holdings Ltd (PK) has traded in the range of US$ 0,1882 to US$ 0,1903 during the past year
What is the PE ratio of Lees Pharmaceutical Holdings Ltd (PK)?
The price to earnings ratio of Lees Pharmaceutical Holdings Ltd (PK) is 6,6
What is the cash to sales ratio of Lees Pharmaceutical Holdings Ltd (PK)?
The cash to sales ratio of Lees Pharmaceutical Holdings Ltd (PK) is 0,42
What is the registered address of Lees Pharmaceutical Holdings Ltd (PK)?
The registered address for Lees Pharmaceutical Holdings Ltd (PK) is Building 20E, Sha Tin, New Territories
What is the Lees Pharmaceutical Holdings Ltd (PK) website address?
The website address for Lees Pharmaceutical Holdings Ltd (PK) is www.leespharm.com
Which industry sector does Lees Pharmaceutical Holdings Ltd (PK) operate in?
Lees Pharmaceutical Holdings Ltd (PK) operates in the Pharmaceuticals sector

LPCUF Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock